why choose us

First received: January 18, 2023

Clinical Trial: A Study of EBC-129 in Advanced Solid Tumours

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Solid Tumours

Study Type: INTERVENTIONAL


Official Title: A Phase 1A/B Study To Evaluate The Safety And Tolerability Of EBC-129 As A Single Agent And In Combination With Pembrolizumab In Advanced Solid Tumours

Brief Summary: This study will assess the safety and tolerability of EBC-129 as a single agent and in combination with pembrolizumab in patients with advanced solid tumours

Read more